Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01003470
Other study ID # KTRDP- 2006BAI12B02-2
Secondary ID
Status Recruiting
Phase Phase 2
First received October 27, 2009
Last updated October 27, 2009
Start date October 2006
Est. completion date October 2010

Study information

Verified date October 2009
Source Tianjin University of Traditional Chinese Medicine
Contact Lixin Fu, M.D.
Phone 86-13821316617
Email fulixin66@126.com
Is FDA regulated No
Health authority China: Ministry of Health
Study type Interventional

Clinical Trial Summary

The purpose of this study is to evaluate the therapeutic effect of acupuncture method of "Xing Nao Kai Qiao" for paralysis as an apoplectic sequela in a multicenter randomized and controlled clinical trial and to compare the efficacy between acupuncture and rehabilitation therapy. In addition, evaluating the trial in the view of medical economics.


Description:

This study is a multi-center randomized controlled trial comparing three treatment groups.The trial is completed in the following three hospitals: First Teaching Hospital of Tianjin University of Traditional Chinese Medicine (TCM) of China, Tianjin Hospital of TCM of China, and Qingdao Haici Medical group of Shangdong province of China.

The total observation period within this study is 24 weeks for each patient. All patients should remain hemiplegia within 15~90 days after stroke. After randomization the patients will receive 4 sessions of 30 minutes' duration during a period of 4 weeks. The outcome measurement is completed both in the different times as follows: before treatment, after the first treatment, 7, 14, 28days after treatment and follow up at 6 months after treatment.

288 patients were randomised into three groups: acupuncture group, rehabilitation group,and acupuncture plus rehabilitation group.The patients in the three groups are blinded as to which treatment method they received. The central randomization is used in this trial, which is performed by the Drug Clinical Research Center of Shanghai University of TCM of China. This trial is performed according to the principles of the Declaration of Helsinki (Version Edinburgh 2000). And the trial protocol has been approved by local institutional review board and ethics committee.


Recruitment information / eligibility

Status Recruiting
Enrollment 288
Est. completion date October 2010
Est. primary completion date October 2009
Accepts healthy volunteers No
Gender Both
Age group 40 Years to 75 Years
Eligibility Inclusion Criteria:

1. Cerebral infarction diagnosed according to the diagnostic standard of western medicine

2. Apoplexy diagnosed according to the diagnostic standard of traditional Chinese medicine for apoplexy

3. Cerebral vascular accident occured in the internal carotid artery system which was verified by cerebral CT or MRI

4. The incidence of apoplexy less than twice and the time of onset 15~3 months

5. Age: 40-75 years, non-limited gender

6. NDS score of limb functional defect =10

7. The patient was alert and the vital signs are stable

8. Participant signed the informed consent form

Exclusion Criteria:

1. TIA or RIND

2. The nerve function defect induced by the cerebral tumor, trauma, parasitic diseases, heart disease and metabolic disorder or hemorrhagic cerebrovascular disease

3. Pregnant or breast-feeding women

4. Complicated with severe primary disease in heart, liver, kidney and hematology system or psychopath

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Other:
acupuncture
Xing Nao Kai Qiao Acupuncture
Behavioral:
rehabilitation
Kinesitherapy
Other:
acupuncture and rehabilitation
Xing Nao Kai Qiao Acupuncture plus Kinesitherapy

Locations

Country Name City State
China First Teaching Hospital of Tianjin University of Traditional Chinese Medicine (TCM) Tianjin Tianjin

Sponsors (1)

Lead Sponsor Collaborator
Tianjin University of Traditional Chinese Medicine

Country where clinical trial is conducted

China, 

References & Publications (1)

Shiflett SC. Does acupuncture work for stroke rehabilitation: what do recent clinical trials really show? Top Stroke Rehabil. 2007 Jul-Aug;14(4):40-58. Review. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Score of neurological defect before treatment, after the first treatment, 7, 14, 28days after treatment and follow up at 6 months after treatment. Yes
Secondary Visualized anologue score before treatment, after the first treatment, 7, 14, 28days after treatment and follow up at 6 months after treatment. Yes
Secondary Spasm evaluation before treatment, after the first treatment, 7, 14, 28days after treatment and follow up at 6 months after treatment. Yes
Secondary Safety evaluation before treatment, after the first treatment, 7, 14, 28days after treatment and follow up at 6 months after treatment. Yes
See also
  Status Clinical Trial Phase
Withdrawn NCT02551003 - Neuroprotective Effect of Autologous Cord Blood Combined With Therapeutic Hypothermia Following Neonatal Encephalopathy Phase 1/Phase 2
Completed NCT03281590 - Stroke and Cerebrovascular Diseases Registry
Recruiting NCT03605381 - MORbidity PRevalence Estimate In StrokE
Completed NCT00684515 - Trial to Assess the Safety of Vorapaxar in Japanese Subjects With Cerebral Infarction (P05005; MK-5348-017) Phase 2
Not yet recruiting NCT04082091 - Screening, Early Referral and Lifestyle Tailored E_prescription for Cardiovascular Prevention
Completed NCT01915368 - Determining Optimal Post-Stroke Exercise (DOSE) N/A
Terminated NCT01684462 - The Efficacy and Safety Study of ALbumin Therapy in Acute Ischemic Stroke Phase 2
Completed NCT00386191 - Safety and Efficacy of Clopidogrel for Cerebral Infarction Treatment Phase 4
Completed NCT00004734 - Vitamin Therapy for Prevention of Stroke Phase 3
Completed NCT02684825 - Detection of Silent Atrial Fibrillation aFter Ischemic StrOke N/A
Completed NCT02248233 - Nimodipine for Treating Acute Massive Cerebral Infarction Phase 4
Completed NCT02963545 - TSK (Tryptophan - Serotonin - Kynurenine) Biomarkers Assessment in Stroke N/A
Completed NCT02511249 - Early Determinants of Multidimensional Outcome at School Age After Neonatal Arterial Ischemic Stroke N/A
Completed NCT02101606 - Penumbral Based Novel Thrombolytic Therapy in Acute Ischemic Stroke Phase 2
Completed NCT01500421 - Safty and Feasibility Study of Therapeutic Cooling in Acute Ischemic Stroke (COOLAID Øresund) Phase 2
Completed NCT00829361 - Stroke Telemedicine for Arizona Rural Residents Trial N/A
Terminated NCT00331890 - ICTUS Study: International Citicoline Trial on Acute Stroke Phase 3
Not yet recruiting NCT04696523 - Effect of Xenon on Brain Injury After Aneurysmal Subarachnoid Hemorrhage Phase 2
Completed NCT03741400 - Virtual Reality Glove for Hand and Arm Rehabilitation After Stroke N/A
Recruiting NCT04908241 - Telerehabilitation With Aims to Improve Lower Extremity Recovery Post-Stroke (TRAIL-RCT) N/A

External Links